Gainers
- GH Research GHRS shares rose 27.4% to $13.5 during Monday's pre-market session. The market value of their outstanding shares is at $702.3 million.
- HCW Biologics HCWB shares rose 25.08% to $0.35. The market value of their outstanding shares is at $15.5 million.
- Invivyd IVVD shares moved upwards by 23.0% to $0.44. The market value of their outstanding shares is at $52.6 million.
- ProPhase Labs PRPH shares moved upwards by 21.95% to $0.32. The market value of their outstanding shares is at $9.7 million.
- Universe Pharmaceuticals UPC shares moved upwards by 15.06% to $0.47. The company's market cap stands at $4.0 million.
- Cutera CUTR stock rose 14.29% to $0.49. The company's market cap stands at $9.8 million.
Losers
- Viracta Therapeutics VIRX shares fell 45.3% to $0.08 during Monday's pre-market session. The market value of their outstanding shares is at $3.2 million.
- AirSculpt Technologies AIRS shares fell 16.29% to $4.01. The company's market cap stands at $232.1 million.
- Annovis Bio ANVS shares decreased by 14.79% to $4.15. The company's market cap stands at $57.2 million.
- icad ICAD stock fell 14.38% to $2.74. The market value of their outstanding shares is at $72.2 million.
- Nuvectis Pharma NVCT stock fell 13.17% to $5.87. The market value of their outstanding shares is at $113.4 million.
- Orchestra BioMed Hldgs OBIO stock fell 12.22% to $4.6. The market value of their outstanding shares is at $173.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ANVSAnnovis Bio Inc
$4.10-15.8%
CUTRCutera Inc
$0.488414.3%
GHRSGH Research PLC
$11.7510.8%
HCWBHCW Biologics Inc
$0.2545-8.52%
ICADicad Inc
$3.20-%
IVVDInvivyd Inc
$0.36120.98%
NVCTNuvectis Pharma Inc
$5.87-13.2%
OBIOOrchestra BioMed Holdings Inc
$4.60-12.2%
PRPHProPhase Labs Inc
$0.320021.5%
UPCUniverse Pharmaceuticals Inc
$0.466415.2%
VIRXViracta Therapeutics Inc
$0.0779-48.6%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in